Heart Rhythm 2026 in Chicago will include a total of 18 late-breaking clinical trials—and that is just the beginning. The four-day event kicks off April 23.
The FDA asked, and Eli Lilly and Company delivered. The company now hopes to secure an additional approval for orforglipron/Foundayo that covers the treatment of type 2 diabetes.
Of all lawsuits filed against patients in 2024 in one U.S. state, physician practices and other non-hospital healthcare entities accounted for 80% of cases. That’s a complete inversion from just six years prior.
In the three or so years since it burst into healthcare, ambient AI scribe technology has run away with the win in the market-uptake race. What has been the return on investment in all those software packages?
The U.S. Department of Justice said it worries its lawsuit could ultimately bankrupt the telehealth group, leaving little money for alleged victims. The company is said to have refused to cancel member accounts, forcing patients to file credit card disputes to get refunds. This is in addition to other arguably more serious accusations levied by the DOJ.
Philips has launched a new 'AI Marketplace' that expands access to third-party diagnostic tools. The company's goal is to put a variety of offerings into one convenient location for clinicians.
Former ACC president Kim Allan Williams Sr., MD, thinks cardiologists should be much more proactive. Encouraging healthy eating habits now, for example, can keep patients out of the hospital later in life and reduce healthcare spending.
Researchers with the Neiman Health Policy Institute recently investigated how COVID-related care site shifts impacted diagnostic radiology, sharing their findings in JACR.
